通过抑制RHOA抑制,SMARCA4抑制乳腺癌的进展和转移
Zheng Sun1,2, Zhuo Li1, Yong Wei1,2
1Department of Molecular Biology, Princeton University, Princeton, New Jersey.
Cancer research
|February 24, 2025
概括
三阴性乳腺癌 (TNBC) 的生长和转移被SMARCA4抑制,这是SWI/SNF复合体的一个子单元. 失去SMARCA4会破坏ARHGAP29的转录,并激活RHOA信号,促进瘤的侵袭性进展.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 三阴性乳腺癌 (TNBC) 由于其侵略性和缺乏向治疗方法,因此存在重大治疗挑战.
- 识别新型调节剂对于开发有效的TNBC疗法至关重要.
研究的目的:
- 使用全基因组CRISPR淘汰屏幕识别三阴性乳腺癌 (TNBC) 的关键调节者.
- 研究SWI/SNF复合体,特别是SMARCA4在TNBC进展中的作用.
主要方法:
- 全基因组的CRISPR淘汰屏幕在2D细胞培养和3D瘤球形模型中进行.
- 该研究利用多个TNBC模型来评估瘤生长,转移和信号通路.
- 机理学研究涉及评估DNA可访问性,基因转录和蛋白质信号.
主要成果:
- 3D瘤球形模型有效地识别了与体内条件相关的瘤抑制剂.
- 失去了SWI/SNF ATPase亚单元SMARCA4,促进了TNBC球状生长,减少了紧性,增强了原发性瘤生长和转移.
- SMARCA4的损失导致ARHGAP29的转录减少和RHOA的信号过活,破坏细胞粘附并促进瘤的攻击性.
结论:
- 通过维持ARHGAP29转录和抑制RHOA信号传递,SMARCA4在TNBC中充当瘤抑制剂.
- 通过SMARCA4,SWI/SNF复合体在抑制TNBC生长和转移方面发挥着关键作用.
- 针对SMARCA4-ARHGAP29-RHOA轴为TNBC提供了一个潜在的治疗策略.
相关概念视频
01:24Small GTPases - Ras and Rho
3.9K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.9K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
02:34Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
02:23Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
02:38The Ras Gene
6.1K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.1K
01:21Cell Polarization by Rho Proteins
2.6K
Cell polarity is the asymmetric distribution of cellular and membrane components, making one side of the cell different from the other. This polarity is essential to many processes such as embryogenesis, axon migration, glucose transport across epithelial cells, and directional cell migration. A migrating cell responds to intracellular or extracellular signals via molecular cascades that reorganize the actin cytoskeleton to establish this polarity. In these cells, the Rho family proteins Cdc42,...
2.6K